Delivery Order SPE2DB22D1202-SPE2DB24FURD4
Award Date
2/21/24
Potential Completion Date
2/22/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,791.68 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565712536 OLUMIANT 4 MG TABLET 30S, a prescription medication. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,691.83 firm fixed-price order is for OLUMIANT 2 MG TABLET 30S, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $4,062.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a medical product, with a period of performance through February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,903.02, is a Firm Fixed Price Delivery Order for the supply of OLUMIANT 2 MG TABLET 30S. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,842.08 firm fixed-price delivery order is for the supply of OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN1C4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,015.93 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. government awarded a $12,900.22 firm fixed price delivery order contract (SPE2DX15D6044|SPE2DX24FCQTA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564239570 - OLUMIANT 4 MG TABLET 30S. This award is a child contract to a $999,999,999.00 indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The IDC serves as the primary vehicle for...
This federal contract award, valued at $1,746.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a delivery order, with a firm fixed-price pricing type. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,407.58 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award is for the delivery of OLUMIANT 4 MG TABLET 30S pharmaceutical products to the U.S. government. The award, valued at $46,714.18, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...